ArticleBMC cancer2024

Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer.

Ji-Yuan Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.